Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinal maculopathy possibly associated with amiodarone medication

J D Thystrup1, H C Fledelius

  • 1Department of Ophthalmology, Hillerød County Hospital, Denmark.

Acta Ophthalmologica
|October 1, 1994
PubMed
Summary

A 59-year-old woman developed wet maculopathy during amiodarone treatment. Despite the drug, her vision stabilized after laser therapy, suggesting the eye condition and amiodarone were unrelated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The usefulness of the Retinomax autorefractor for childhood screening validated against a Danish preterm cohort examined at the age of 4 years.

Eye (London, England)·2015
Same author

Down's syndrome and early cataract.

The British journal of ophthalmology·2006
Same author

ROP was always there.

Eye (London, England)·2005
Same author

Liposarcoma metastatic to the orbit.

European journal of ophthalmology·2003
Same author

Neoplasia versus hyperplasia of the retinal pigment epithelium. A comparison of two cases.

Acta ophthalmologica Scandinavica·2002
Same author

[Follow-up of children with congenital toxoplasmosis].

Ugeskrift for laeger·2001

Area of Science:

  • Ophthalmology
  • Cardiology
  • Pharmacology

Background:

  • Amiodarone is a widely used antiarrhythmic drug for cardiac disorders.
  • Ocular side effects of amiodarone are well-documented, but central retinopathy is rare.

Observation:

  • A 59-year-old female patient on amiodarone therapy developed wet maculopathy in her only seeing eye.
  • The patient had a cardiac disorder requiring amiodarone treatment.

Findings:

  • Following amiodarone withdrawal and central retinal laser therapy, the patient's visual acuity stabilized at 0.7.
  • The follow-up period was 6 years.
  • No similar cases of amiodarone-associated central retinopathy were found in the literature.

Implications:

Related Experiment Videos

  • The observed central retinopathy in this case may be coincidental and not directly caused by amiodarone.
  • Further research is needed to clarify the potential ocular risks of amiodarone therapy.
  • Ophthalmologists should remain vigilant for potential visual disturbances in patients treated with amiodarone.